维普期刊资源整合服务平台（V6.5）

402篇 您的检索式：作者名="Porta C"

选中清除导出查看参考文献查看引证文献引用追踪共21页首页上一页第1页下一页末页 /21 跳转

	题名	作者	年代	出处	被引量
1	Mutation analysis of the inhibin α gene in a cohort of Italian women affected by ovarian failure显示文摘	MAROZZI A PORTA C VEGETH W	2002	Hum Reprod2002，17，7：	1
2	Slow breathing improves arterial baroreflex sensitivity and decreases blood pressure in es- sential hypertension 显示文摘	Joseph CN Porta C Casucci G	2005	Hypertension2005，46，4：	1
3	Recombinant human interleukin-11 (neumega, rhIL11) reduces thrombocytopenia in breast cancer patients receiving tandem autolous circulating progenitor cell transportation 显示文摘	Ferrari S Danova M Porta C	2002	Ann Hematol2002，81，6：	1
4	Phosphatidylinositol - 3 - kinase/Akt signaling pathway and kidney cancer, and the therapeutic potential of phosphatidylinositol - 3 - kinase/Akt inhibitors 显示文摘	Porta C Figlin RA	2009	J Urol2009，182，6：	1
5	Changes in proteinkinase C alpha,delta and in nuclear beta isoform expressionin tumour and lung metastatic nodules induced by diethylni-trosamine in the rat显示文摘	La Porta C A Tessitore L Comolli R	1997	Carcinogenesis1997，18，4：	1
6	Erlotinib customization based on epidermal growth factor receptor (EGFR) mutations in stage Ⅳ non-small-cell lung cancer (NSCLC) patients显示文摘	Porta R Queralt C Cardenal F	2008	J Clin Oncol2008，26，：	1
7	Heart rate variability explored in the frequency domain:a tool to investigate the link between heart and behavior显示文摘	Montano N Porta A Cogliati C	2009	Neuresci Biobehav Rev2009，33，2：	1
8	Multicenter validation of a reproducibleflow cytometric score for the diagnosis of low-grademyelodysplastic syndromes:results of a EuropeanLeukemia NET study显示文摘	DELLA PORTA MG PICONE C PASCUTTOC	2012	Haematologica2012，97，8：	1
9	Circulating interleukin-6as a tumor marker for hepatocellular carcinoma显示文摘	Porta C De Amici M Quaglini S	2008	Ann Oncol2008，19，2：	1
10	Endothelin-1 and 5-fluoroura- cil-induced cardiotoxicity显示文摘	Porta C Moroni M Ferrari S	1998	Neoplasma1998，45，2：	1
11	Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System(WPSS)显示文摘	Malcovati L Della Porta M G Strupp C	2011	Haematologica2011，96，10：	1
12	A new P-glycoprotein inhibitor from the caper spurge(Euphorbia lathyris)显示文摘	Appendino G Porta C D Conseil G	2003	J Nat Prod2003，，：	1
13	Trends in pancreatic cancer mortality in Europe 显示文摘	Fernandez E La Vecchina C Porta M	1994	Int J Cancer1994，57，6：	1
14	Thrombotic thrombocytopenic purpura treatment in year 2000显示文摘	Rock G Porta C Bobbi-Pallavicini E	2000	Haematologica2000，85，：	1
15	BBR3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer:a phase II study group trial of the Central European Society of Anticancer-Drug Research (CESAR) 显示文摘	Hofheinz R D Porta C Hartung G	2005	Invest New Drugs2005，23，4：	1
16	Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study显示文摘	Escudier B Porta C Bono P	2014	J Clin Oncol2014，32，14：	1
17	Safety and efficacy of sunitinib for metastatic renal - cell carcinoma: an expanded - access trial 显示文摘	Gore ME Szczylik C Porta C	2009	The lancet oncology2009，10，8：	1
18	Safety and efficacy of sunitinib for metastatic renal-cell carcinoma:an expanded-access trial显示文摘	Gore M E Szczylik C Porta C	2009	Lancet Oncol2009，10，8：	1
19	Tumor promotion by tumor-associated macrophages显示文摘	Porta C Subhra Kumar B Larghi P	2007	Adv Exp Med Biol2007，604，：	1
20	Mutation analysis of the inhibin alpha gene in a cohort of Italian women affected byovarian failure显示文摘	Marozzi A Porta C Vegetti W	2002	Hum Reprod2002，17，7：	1

返回顶部每页显示：

共21页首页上一页第1页下一页末页 /21 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示